Breakthrough ear tube device could make surgery obsolete for kids

NCT ID NCT05741333

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called Solo+ that places tiny tubes in the eardrums of children with ear infections. The goal is to see if it is safe and effective when done in a doctor's office instead of an operating room. About 66 children aged 6 months to 12 years will be enrolled. The device aims to simplify treatment and reduce the need for general anesthesia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Solo+ Tympanostomy Tube Device
What this could lead to
If successful, this device could offer a simpler, in-office way to place ear tubes in children, reducing the need for general anesthesia.
What could go wrong
This is a small, early-stage study with only 66 participants, so results may not apply to all children. Risks include device-related complications like infection or tube blockage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EAR INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced ENT & Allergy

    Louisville, Kentucky, 40220, United States

  • East Alabama ENT

    Opelika, Alabama, 36801, United States

  • North Alabama ENT

    Huntsville, Alabama, 35801, United States

  • Sacramento ENT

    Sacramento, California, 95661, United States

  • South Carolina ENT

    Columbia, South Carolina, 29203, United States

  • Southern Head & Neck Surgery

    Alexander City, Alabama, 35010, United States

  • Specialty Physician Associates

    Bethlehem, Pennsylvania, 18017, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.